Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Guardant Health Inc (GH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Guardant Health's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25.36 -0.88    -3.35%
17/05 - Closed. Currency in USD ( Disclaimer )
After Hours
25.35
-0.01
-0.04%
19:31:23 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,431,125
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 25.07 - 26.50
Guardant Health 25.36 -0.88 -3.35%

GH Recent Sentiments

 
This page contains information on users’ sentiments for the Guardant Health Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 23, 2024 giuseppe langella   18.16 May 17, 2024 @ 25.36 +39.65%
Apr 02, 2024 king black   20.65 Apr 08, 2024 @ 18.54 -10.22%
Apr 01, 2024 Livio Valli   20.98 Apr 08, 2024 @ 18.54 -11.63%
Mar 28, 2024 Jonathan Pons   20.02 Apr 19, 2024 @ 16.07 -19.73%
Mar 28, 2024 giuseppe langella   20.27 Apr 19, 2024 @ 16.07 -20.72%
Mar 28, 2024 Stephen Clarke   19.74 Apr 01, 2024 @ 19.61 -0.66%
Jan 23, 2024 Jonathan Pons   22.97 Feb 16, 2024 @ 22.42 -2.39%
Jan 23, 2024 niccolò francoise de...   23.25 Feb 16, 2024 @ 22.42 -3.57%
Dec 27, 2023 niccolò francoise de...   27.95 Jan 19, 2024 @ 23.21 -16.96%
Dec 12, 2023 Marat MINLEBAEV   26.91 Dec 18, 2023 @ 27.35 +1.64%
Sep 14, 2023 Paky Paky   30.56 Nov 30, 2023 @ 25.12 -17.80%
Sep 13, 2023 Jonathan Pons   32.41 Nov 30, 2023 @ 25.12 -22.49%
Aug 18, 2023 Valen PF   36.44 Nov 30, 2023 @ 25.12 -31.06%
Jul 13, 2023 Игорь Малиновский   38.81 Nov 30, 2023 @ 25.12 -35.27%
Jun 15, 2023 Sander Haungaard   37.84 Nov 30, 2023 @ 25.12 -33.62%
May 22, 2023 Roman Soldat   31.04 Nov 30, 2023 @ 25.12 +19.07%
May 17, 2023 Giuseppe De Santis   28.21 Nov 30, 2023 @ 25.12 -10.95%
May 03, 2023 Erol Teberoglu   21.59 May 09, 2023 @ 23.53 +8.99%
Apr 25, 2023 Na Niu   21.79 May 11, 2023 @ 27.11 +24.41%
Apr 19, 2023 Roman Soldat   25.22 Apr 24, 2023 @ 23.91 +5.19%
Mar 31, 2023 Nina Rożniata   23.60 Apr 03, 2023 @ 24.13 +2.25%
Mar 30, 2023 Vincenzo Carabillò   22.67 Apr 21, 2023 @ 24.51 +8.12%
Mar 23, 2023 illus park   24.30 Apr 14, 2023 @ 24.50 +0.82%
Mar 22, 2023 Roman Soldat   26.05 Mar 27, 2023 @ 23.93 +8.14%
Feb 16, 2023 Jonathan Pons   29.69 Mar 10, 2023 @ 25.01 -15.76%
Feb 16, 2023 Николай Ермаков   29.54 Mar 10, 2023 @ 25.01 -15.34%
Feb 03, 2023 Diana Makazhanova   30.75 Feb 24, 2023 @ 28.88 -6.08%
Dec 21, 2022 Jose Veras   30.23 Jan 13, 2023 @ 30.43 +0.66%
Dec 16, 2022 Ruslan Udin   28.23 Dec 19, 2022 @ 30.06 +6.48%
Dec 14, 2022 Valen PF   41.98 Jan 06, 2023 @ 25.95 -38.18%
Dec 13, 2022 Carlton HALL   46.58 Dec 13, 2022 @ 46.66 +0.17%
Nov 03, 2022 Eduard Naumov   45.88 Nov 28, 2022 @ 51.52 +12.29%
Oct 28, 2022 Carlos PEPE Garcia   45.96 Oct 31, 2022 @ 49.32 +7.31%
Oct 25, 2022 Uwe Balsottemeyer   46.69 Nov 18, 2022 @ 48.18 +3.19%
Oct 14, 2022 iana perova   50.42 Oct 17, 2022 @ 50.72 +0.60%
Oct 10, 2022 Eric Kiehl   52.57 Nov 04, 2022 @ 47.27 +10.08%
Aug 24, 2022 احمد الغامدي   50.20 Aug 29, 2022 @ 49.37 -1.65%
Aug 17, 2022 Christine Vandezande   51.19 Sep 09, 2022 @ 59.28 +15.80%
Aug 17, 2022 Christine Vandezande   51.19 Sep 09, 2022 @ 59.28 +15.80%
Aug 17, 2022 Christine Vandezande   51.19 Sep 09, 2022 @ 59.28 +15.80%
Aug 17, 2022 Christine Vandezande   51.19 Sep 09, 2022 @ 59.28 +15.80%
Aug 17, 2022 Christine Vandezande   51.19 Sep 09, 2022 @ 59.28 +15.80%
Aug 17, 2022 Christine Vandezande   51.19 Sep 09, 2022 @ 59.28 +15.80%
Aug 17, 2022 Christine Vandezande   51.19 Sep 09, 2022 @ 59.28 +15.80%
Aug 08, 2022 ricardo fuster   56.71 Aug 15, 2022 @ 55.09 -2.86%
Jun 08, 2022 Drew Coleman   42.99 Jul 01, 2022 @ 43.66 -1.56%
May 27, 2022 Zoltan Repasi   43.17 Jun 17, 2022 @ 37.13 -13.99%
May 23, 2022   36.80 Jun 17, 2022 @ 37.13 +0.90%
May 09, 2022 Antonio Framis   32.46 May 16, 2022 @ 35.58 +9.61%
May 09, 2022 Arun Patti   33.85 Jun 03, 2022 @ 38.03 -12.35%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GH Comments

Write your thoughts about Guardant Health Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Seungyeon Sam Han
Seungyeon Sam Han Mar 22, 2022 8:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Number one player in the liquid biopsy, but macro enviroment is likely dragging down the price further..?!
Nguyen Anh
Nguyen Anh Nov 25, 2021 1:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no divided shares
Peter Spinella
Peter Spinella Nov 05, 2021 10:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GH has all the right elements to be a $180 stock with a year in a hot segment
FR Monta
FR Monta Sep 15, 2020 1:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I am so imptient to see Q3 figures with FDA approval on blood test and covid test 🚀🚀
Gyal TR
Gyal TR Sep 14, 2020 3:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
doing well...
Alfredo Pacheco Jr
Fredo Mar 12, 2020 8:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
one of the only stocks to actually have gains......I missed my chance
Wojciech Stefaniak
Wojciech Stefaniak Feb 25, 2020 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I was right, inept people are written reccomendations for money given by such sh... company like GH.
Wojciech Stefaniak
Wojciech Stefaniak Sep 16, 2019 3:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I followed zacks.com reccommendations but simply; worth for nothing (so many others)!
Daniel Lai
Daniel Lai Sep 16, 2019 2:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hope GH will fall to 30 lol
The Oracle
The Oracle Sep 12, 2019 3:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is a tremendous company: it was though impossible to buy at the levels it reached: now it is starting to have some serious upside.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email